In the prospective cohort GENEPSO, which aims at assessing environmental and lifestyle risk factors, BRCA1/2 mutation carriers are followed over time to observe characteristics of subjects who are developing either primary or secondary cancer. This evidence concerns the gene BRCA1 and cancer.